Evidence map›Paper›PMID 40943490›Full record

ArticleInternational journal of molecular sciences2025

Multifunctional Activity of

Daria Derkacz, Liliana Cebula, Anna Krasowska

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Daria DerkaczDepartment of Biotransformation, Faculty of Biotechnology, University of Wroclaw, F. Joliot-Curie 14A, 50-383 Wroclaw, Poland.ORCID 0000-0002-9629-9451
Liliana CebulaDepartment of Biotransformation, Faculty of Biotechnology, University of Wroclaw, F. Joliot-Curie 14A, 50-383 Wroclaw, Poland.ORCID 0009-0003-6002-0601
Anna KrasowskaDepartment of Biotransformation, Faculty of Biotechnology, University of Wroclaw, F. Joliot-Curie 14A, 50-383 Wroclaw, Poland.ORCID 0000-0002-1925-193X

Funding

National Science Center 2021/43/B/NZ1/00523
6 · The paper itself

Abstract

Eugenol is a compound with promising antimicrobial properties. The rising phenomenon of multidrug resistance of

Indexed as

Antifungal AgentsCandida albicansCell Membrane PermeabilityFungal ProteinsPlant ExtractsSyzygiumCell MembraneEugenolFree RadicalsMembrane FluidityMembrane Transport ProteinsMicrobial Sensitivity TestsReactive Oxygen SpeciesAntifungal AgentsCDR1 protein, Candida albicansEugenolFree RadicalsFungal ProteinsMembrane Transport ProteinsPlant ExtractsReactive Oxygen SpeciesCandida albicanseugenolplasma membrane

Identifiers

PMID40943490
PMCPMC12429323

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.